logo

For the Inventor, By the Inventor

Burlingame, CA, United States of America

Corvus Pharmaceuticals, Inc.


USPTO Granted Patents = 15



Forward Citations = 8

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Richard A Miller (10 out of 25 patents)

silverMedal Stephen Willingham (5 out of 18 patents)

bronzeMedal Andrew Hotson (5 out of 5 patents)

4.  Ian Mccaffery (5 out of 5 patents)

5.  Emily Piccione Griffin (4 out of 7 patents)

6.  Ryan Hudson (3 out of 41 patents)

7.  Anne-Marie Beausoleil (3 out of 32 patents)

8.  Hwai Wen Chang (2 out of 54 patents)

9.  Gerhard Johann Frey (2 out of 83 patents)

10.  Po Y Ho (2 out of 2 patents)

11.  William Benton Jones (2 out of 2 patents)

12.  Erik J Verner (2 out of 83 patents)

13.  Zhihong Li (1 out of 16 patents)

14.  Jingrong Xu (1 out of 1 patent)

15.  Felicia Flicker (1 out of 1 patent)


15 patents:

1. 12351644 - Anti-CD73 antibodies (2025-07-08),
2. 12174192 - Methods for detecting and treating cancers having adenosine pathway activation (2024-12-24),
3. 12116635 - Methods for detecting and treating cancers having adenosine pathway activation (2024-10-15),
4. 12023337 - Methods of treating cancer (2024-07-02),
5. 11897874 - Compounds and methods for modulating Interleukin-2-inducible T-cell kinase (2024-02-13),
6. 11859007 - Humanized anti-CD73 antibodies (2024-01-02),
7. 11266649 - Pharmaceutical formulations (2022-03-08),
8. 11254686 - Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor (2022-02-22),
9. 11040040 - Methods of treating cancer (2021-06-22),
10. 11008314 - Compounds and methods for modulating interleukin-2-inducible t-cell kinase (2021-05-18),
11. 10912776 - Methods of treating cancer (2021-02-09),
12. 10870652 - Compounds and methods for modulating bruton's tyrosine kinase (2020-12-22),
13. 10822426 - Humanized anti-CD73 antibodies (2020-11-03),
14. 10793636 - Anti-CD73 antibodies (2020-10-06),
15. 10654825 - Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof (2020-05-19),
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology therapies. The company's lead product candidate, CPI-006, is a novel immunotherapy that activates T cells to target and destroy cancer cells.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

15 Patents

#11 in Burlingame, CA

#4,877 in California

#20,443 in US

#38,742 in the World

...
Burlingame, CA, United States of America

Corvus Pharmaceuticals, Inc.

Forward Citations = 8

20 inventors:

goldMedal Richard A Miller (10 out of 25 patents)

silverMedal Stephen Willingham (5 out of 18 patents)

bronzeMedal Andrew Hotson (5 out of 5 patents)

4.  Ian Mccaffery (5 out of 5 patents)

5.  Emily Piccione Griffin (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…